GOSSAMER BIO, INC. (GOSS) Debt / Equity
- 2024-12-31: Debt/Equity Ratio 0.
- 2024-09-30: Debt/Equity Ratio 0.
- 2024-06-30: Debt/Equity Ratio 0.
- 2024-03-31: Debt/Equity Ratio 0.36.
Complete source-backed debt/equity ratio history.
- Available history
- 2021-12-31 to 2024-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|
| 2024-12-31 | 0 |
|---|
| 2024-09-30 | 0 |
|---|
| 2024-06-30 | 0 |
|---|
| 2024-03-31 | 0.36 |
|---|
| 2023-12-31 | 0.2 |
|---|
| 2023-09-30 | 0.15 |
|---|
| 2023-06-30 | -0.29 |
|---|
| 2023-03-31 | -0.73 |
|---|
| 2022-12-31 | 1.95 |
|---|
| 2021-12-31 | 0.24 |
|---|
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|
| 2024-12-31 | 0 |
|---|
| 2023-12-31 | 0.2 |
|---|
| 2022-12-31 | 1.95 |
|---|
| 2021-12-31 | 0.24 |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|